SLN - Silence Therapeutics plc Operatsion marja

Silence Therapeutics (SLN) kompaniyasining rasmiy ramzlari

RNKga asoslangan yurak terapiyasi bozori ulkan salohiyatga ega bo'lib, bu Silence Therapeutics (SLN) va sog'liqni saqlash gigantlari o'rtasidagi B2B hamkorligini rag'batlantirmoqda. Operatsion marja tendentsiyasi daromadlilikning tiklanishining joriy bosqichini aks ettiradi, bunda parametr -11919.90 qiymatiga yetadi. siRNA platformasining muvaffaqiyatlari va litsenziyalash to'lovlari aksiyalar narxining ko'tarilishini qo'llab-quvvatlamoqda, dori vositalarini yetkazib berishning noyob usullari esa kompaniyaga narxlarni belgilash imkoniyatini beradi.

SLN - Silence Therapeutics PLC Operatsion marja 21.06.2023 - 20.11.2026 oraligʻida

SLN (Silence Therapeutics): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:SLN, Silence Therapeutics Corp
Silence Therapeutics Corp tayyor mahsulotlari

Fundamental jihatdan barqaror aktivlarni aniqlash xarajatlarni boshqarish samaradorligining aniq bahosini talab qiladi. Operatsion marja soliqlar va foizlardan oldingi umumiy daromadga nisbatan asosiy biznes operatsiyalardan olingan foyda ulushini belgilaydi. Silence Therapeutics (SLN) uchun ushbu ko'rsatkich RNA interferentsiyasi texnologiyalarini monetizatsiya qilish qobiliyatini aks ettiradi. Dori vositalarini ishlab chiqish samaradorligi operatsion rentabellikka bevosita ta'sir ko'rsatadi. Operatsion marjadagi o'zgarishlarni tahlil qilish orqali investor kompaniyaning biznes modelining barqarorligini baholaydi.

Raqobatchilar tahlili

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Operatsion rentabellik SLDB (Solid Biosciences)|Ocugen Corp - Sotuvning operatsion marjasi|PACB: Operatsion foyda bo'yicha sotuv rentabelligi|benitec.com - Operatsion marja|DSGN - Operatsion marja|RCKT: Operatsion marja|FDMT (4D Molecular Therapeutics Inc) - Operatsion rentabellik|Sotuvning operatsion marjasi LXEO|Operatsion rentabellik KRRO|Operatsion marja EDIT|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik